ロード中...
The choice between a ritonavir-boosted protease inhibitor- and a non-nucleoside reverse transcriptase inhibitor-based regimen for initiation of antiretroviral treatment – results from an observational study in Germany
BACKGROUND: This study aims at identifying predictors of the treatment decision of German physicians with regard to a non-nucleoside reverse transcriptase inhibitor (NNRTI) or a ritonavir-boosted protease inhibitor (PI/r) -based initial treatment regimen. METHODS: The study is based on a sub analysi...
保存先:
| 出版年: | J Pharm Policy Pract |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5203724/ https://ncbi.nlm.nih.gov/pubmed/28050254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40545-016-0092-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|